Compound Detail
CHEMBL4749009
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4749009 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZVKVWIFOWYIPEN-CYBMUJFWSA-N |
5
Targets
7
Activities
1
Assay Types
6
PK Parameters
7
Publications
0
Known Names
Molecular Properties
383.4
MW (Da)
3.76
ALogP
4
HBA
1
HBD
71.5
PSA (Ų)
0.87
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 8.59
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 8.59 | 7.745 | 2.6 | 2 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.21 | 5.21 | 6200.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.22 | 4.22 | 60000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.22 | 4.22 | 60000.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 14.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 221.0 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 40.0 | % | Rattus norvegicus |
| Fu | 0.094 | - | Homo sapiens |
| Fu | 0.11 | - | Rattus norvegicus |
| T1/2 | 1.1 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 2.6 | nM | 8.59 | Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as reductio... | 33738066 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 127.0 | nM | 6.9 | Inhibition of IDO1 in LPS and IFN-gamma-stimulated human Whole blood assessed as... | 33738066 |
| Cytochrome P450 2C9 | IC50 | = | 6200.0 | nM | 5.21 | Inhibition of CYP2C9 (unknown origin) | 33738066 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 20000.0 | nM | 4.7 | Displacement of [35S]-MK499 binding to human ERG expressed in HEK293 cells incub... | 33738066 |
| Cytochrome P450 3A4 | IC50 | = | 60000.0 | nM | 4.22 | Inhibition of CYP3A4 (unknown origin) | 33738066 |
| Unchecked | IC50 | = | 60000.0 | nM | 4.22 | Inhibition of Na ion channel (unknown origin) | 33738066 |
| Unchecked | IC50 | = | 60000.0 | nM | 4.22 | Inhibition of Ca ion channel (unknown origin) | 33738066 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33738066 | 10.1021/acsmedchemlett.0c00525 | ADMET | 7 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | Indoleamine 2,3-dioxygenase 1 | 3 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | No relevant target | 3 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | Unchecked | 2 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | Cytochrome P450 2C9 | 1 |
| 33738066 | 10.1021/acsmedchemlett.0c00525 | Cytochrome P450 3A4 | 1 |
Data from ChEMBL 36 via Core Engine